Milestone Pharmaceuticals Inc.
MISTNasdaqCIK 1408443HealthcareFiscal year ends Dec 31
Reports and events: 123 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0316:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105052 |
| 2026-08-1207:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094466 |
| 2026-08-1207:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094435 |
| 2026-06-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-074025 |
| 2026-05-1307:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059780 |
| 2026-05-1307:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059752 |
| 2026-04-3016:06 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001104659-26-052880 |
| 2026-03-2007:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-032427 |
| 2026-03-2007:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-032415 |
| 2026-01-2609:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006483 |
| 2026-01-1306:06 ET | 8-K | 8.01 Other events | 0001104659-26-003038 |
| 2026-01-0608:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-001099 |
| 2025-12-1508:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120904 |
| 2025-11-1207:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109744 |
| 2025-11-1206:56 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109689 |
| 2025-08-1207:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076468 |
| 2025-08-1206:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011141 |
| 2025-07-1407:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067579 |
| 2025-07-1106:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067108 |
| 2025-06-1608:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059671 |
| 2025-06-1216:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-058874 |
| 2025-05-1407:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048160 |
| 2025-05-1407:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007648 |
| 2025-04-3017:01 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001104659-25-042640 |
| 2025-03-2807:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029047 |
| 2025-03-1916:05 ET | 8-K | 5.08 Item not in the standard list | 0001104659-25-025547 |
| 2025-03-1816:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-025055 |
| 2025-03-1307:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023218 |
| 2025-03-1307:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002849 |
| 2025-02-2516:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-016929 |
| 2024-11-1209:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116493 |
| 2024-11-1207:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015147 |
| 2024-09-0408:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096648 |
| 2024-08-0816:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087301 |
| 2024-08-0816:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011603 |
| 2024-07-1618:06 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-24-001575 |
| 2024-07-1516:34 ET | DEF 14A | Proxy statementPeriod 2024-08-28 | 0001104659-24-079878 |
| 2024-07-1516:02 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-079854 |
| 2024-05-2907:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-065806 |
| 2024-05-1307:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060221 |
| 2024-05-1306:59 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007860 |
| 2024-04-2917:06 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001104659-24-054157 |
| 2024-04-0816:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-044767 |
| 2024-03-2807:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-040008 |
| 2024-03-2107:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-036941 |
| 2024-03-2107:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003666 |
| 2024-03-0409:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-030267 |
| 2024-02-2607:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-027262 |
| 2023-12-2607:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-128988 |
| 2023-11-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-116646 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.